Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A radioimmunoassay for tallysomycin

A Broughton, J E Strong, S T Crooke

    Cancer Treatment Reports
    |November 1, 1979
    PubMed
    Summary

    Researchers developed a sensitive radioimmunoassay for tallysomycin, a new anticancer drug. The assay is specific for tallysomycin A and shows potential for detecting conformational changes upon metal binding.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Address to the Medical Profession.

    Western journal of medicine and surgery·2024
    Same author

    Address to the Medical Profession, in Relation to the Objects of the National Medical Association, by the Committee Appointed for That That Purpose.

    Medical examiner (Philadelphia, Pa.)·2023
    Same author

    Providing environmentally sustainable nephrology care: focus in low- and middle-income countries.

    Kidney international·2023
    Same author

    Coronavirus disease 2019 subphenotypes and differential treatment response to convalescent plasma in critically ill adults: secondary analyses of a randomized clinical trial.

    Intensive care medicine·2022
    Same author

    Closing the Brief Case: Tropheryma whipplei Infection Resulting in Neurological Symptoms.

    Journal of clinical microbiology·2022
    Same author

    The Brief Case: Tropheryma whipplei Infection Resulting in Neurological Symptoms.

    Journal of clinical microbiology·2022

    Area of Science:

    • Biochemistry
    • Immunology
    • Pharmacology

    Background:

    • Tallysomycin is a novel antineoplastic agent.
    • Development of specific assays is crucial for characterizing such agents.
    • Radioimmunoassays (RIAs) offer high sensitivity and specificity.

    Purpose of the Study:

    • To develop a radioimmunoassay (RIA) for the quantification of tallysomycin.
    • To assess the specificity and sensitivity of the RIA for tallysomycin A.
    • To investigate the effect of metal chelation on tallysomycin's immunoreactivity.

    Main Methods:

    • Antibodies were generated against tallysomycin.
    • A radioimmunoassay (RIA) was established using these antibodies.
    • Cross-reactivity studies were performed with related compounds and other antibiotics.
    • Immunoreactivity of chelated and non-chelated tallysomycin B was compared.

    Main Results:

    • The RIA demonstrated high sensitivity, detecting as little as 2.5 ng of tallysomycin.
    • The assay exhibited excellent specificity for tallysomycin A, with low cross-reactivity to analogs.
    • Minimal immunoreactivity was observed with bleomycin and phleomycin.
    • Copper chelation of tallysomycin B increased its immunoreactivity compared to non-chelated forms.

    Conclusions:

    • A highly sensitive and specific RIA for tallysomycin has been developed.
    • The RIA can differentiate tallysomycin A from related analogs and other antibiotics.
    • Metal binding, such as copper chelation, may induce conformational changes in tallysomycin B, affecting its immunoreactivity.

    Related Experiment Videos